SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 93 filers reported holding SYNTA PHARMACEUTICALS CORP in Q3 2014. The put-call ratio across all filers is 1.91 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $19,000 | -29.6% | 77,700 | 0.0% | 0.00% | – |
| Q4 2015 | $27,000 | -80.3% | 77,700 | -1.2% | 0.00% | – |
| Q3 2015 | $137,000 | -21.7% | 78,624 | 0.0% | 0.00% | – |
| Q2 2015 | $175,000 | +136.5% | 78,624 | +105.2% | 0.00% | – |
| Q1 2015 | $74,000 | 0.0% | 38,324 | +37.7% | 0.00% | – |
| Q4 2014 | $74,000 | -36.2% | 27,824 | -27.8% | 0.00% | – |
| Q3 2014 | $116,000 | +18.4% | 38,524 | +61.0% | 0.00% | – |
| Q2 2014 | $98,000 | -50.0% | 23,924 | -47.4% | 0.00% | – |
| Q1 2014 | $196,000 | -22.8% | 45,445 | -6.3% | 0.00% | – |
| Q4 2013 | $254,000 | -36.8% | 48,524 | -23.8% | 0.00% | – |
| Q3 2013 | $402,000 | -33.8% | 63,667 | -47.7% | 0.00% | -100.0% |
| Q2 2013 | $607,000 | – | 121,707 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 37,061,186 | $82,646,000 | 87.47% |
| Geller Advisors LLC | 187,323 | $418,000 | 0.24% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 430,749 | $961,000 | 0.22% |
| Verity Asset Management, Inc. | 81,694 | $182,000 | 0.16% |
| CAXTON CORP | 52,000 | $116,000 | 0.12% |
| Catalyst Capital Advisors LLC | 400,000 | $892,000 | 0.10% |
| Cutler Capital Management, LLC | 72,500 | $161,000 | 0.07% |
| STONERIDGE INVESTMENT PARTNERS LLC | 239,202 | $533,000 | 0.07% |
| SECOR Capital Advisors, LP | 35,087 | $78,000 | 0.03% |
| Roundview Capital LLC | 29,100 | $65,000 | 0.02% |